RUNX1 and acute myeloid leukemia: Simon et al. found that a notable proportion (27%) of RUNX1 variants in patients with RUNX1-mutant AML were of germline origin (145), and among those, 16% are deleterious when curated using RUNX1-specific curation rules (116, 146–148).